Lotus Eye Hospital and Institute Limited

₹103.99As of Sun 8 Nov 2026, 12:00 UTC
NSE:LOTUSEYEHealthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR 15.52%
Div yield —
ROE 0.13%
Medical Care Facilities
Beta (5Y) 0.60
PE TTM 1,391
TSR TTM (16.83%)
Mkt cap ₹2.163B
ROIC 0.26%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹107
2.90%
152.95%
Hold 8|9|7|2|11
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
1.12
1.16
1.13
1.26
19.81%
17.72%
11.76%
13.77%
Revenue₹M
186.4
195.3
189.8
196.8
10.99%
14.38%
8.70%
8.75%
Peers (US$23.43M)
Cap (US$)
PE
15.24M
36.14x
8.619M
27.07x
Capital
TTM
5Y
10Y
Leveragex
2.425
(1.859)
(1.757)
EBIT/Intx
0.124
0.307
0.313
Own earn%
96.48
(26.47)
(26.00)
Sh yield%
47.72
43.57
42.82
Owners
Insiders/Inst%
0.38
34.19
Short interest%
1.02
SBC / revenue%
2.60
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
0–1
$1 testx
—
Incr. ROIC%
10